1. Introduction {#sec1-pathogens-09-00175}
===============

Bell pepper (*Capsicum annuum* L.) is one of the most widely cultivated vegetable crops in the world. Over the last decade, the world's production and consumption of bell peppers have been steadily increasing. More than 70% of the world's bell peppers are produced in Asia, with China being the largest producer of bell peppers \[[@B1-pathogens-09-00175]\]. The *Fusarium* disease of bell pepper, resulting in external fruit rot, is caused by *F. oxysporum*, *F. proliferatum*, *F. solani*, *F. lactis*, and *F. incarnatum*-*equiseti* species complexes and has been reported to occur in Belgium, Canada, the Netherlands, and the United Kingdom \[[@B2-pathogens-09-00175],[@B3-pathogens-09-00175],[@B4-pathogens-09-00175],[@B5-pathogens-09-00175]\]. Symptoms of external infection include water-soaked, sunken lesions that expand to or originate from the calyx end of the fruit---either in the ripe or immature green stage. Internal fruit rot can also develop where the seeds and placenta become infected and turn black with rot. Residue management, crop rotation, seed treatments, and fungicide use form the general integrated disease management strategies for controlling fungal diseases of bell pepper, and while there is no seed treatment or fungicide that will eliminate these diseases entirely, certain fungicides have been reported to reduce inoculum load (<https://www.cropscience.bayer.ca>). There are no currently available bell pepper cultivars that are resistant or tolerant to *Fusarium* disease but yield and resistance remain the paramount breeding targets for sustainable production.

Between 2010 and 2014, a survey of the major bell pepper growing areas in Trinidad was carried out from which it was reported that fruit rot of bell peppers was caused by two fungal pathogens, *Colletotrichum truncatum* (synonym *C. capsici*; \[[@B6-pathogens-09-00175]\]) and *Fusarium* species including members of the *Fusarium incarnatum-equiseti* species complex (FIESC) \[[@B7-pathogens-09-00175],[@B8-pathogens-09-00175]\]. FIESC isolates are pervasive soil inhabitants and are pathogenic to a range of economically important plant species, including cereals, fruits, and vegetables \[[@B8-pathogens-09-00175],[@B9-pathogens-09-00175],[@B10-pathogens-09-00175],[@B11-pathogens-09-00175]\]. Members of this species complex are able to produce several mycotoxins, which upon consumption, pose health risks to animals and humans \[[@B10-pathogens-09-00175],[@B12-pathogens-09-00175],[@B13-pathogens-09-00175]\]. In humans, several species and species complexes are associated with fusariosis, including *F. incarnatum-equiseti* \[[@B14-pathogens-09-00175],[@B15-pathogens-09-00175],[@B16-pathogens-09-00175],[@B17-pathogens-09-00175]\].

The *EF-1*α (translation elongation factor-1α) gene sequence, with a sequence similarity threshold of 99.4%, is a suitable genetic marker for discriminating among *Fusarium* spp. and allows for discrimination of genotypes to the intraspecific level \[[@B18-pathogens-09-00175],[@B19-pathogens-09-00175]\]. However, reliable identification of unknown isolates and phylogenetic inference is based on sequence data that must be generated for multiple loci apart from *EF-1*α and includes RNA polymerase largest and second-largest subunits (*RPB1* and *RPB2*), and Calmodulin (*CAM*), using the same sequence similarity threshold as for *EF-1*α \[[@B19-pathogens-09-00175]\]. O'Donnell et al. \[[@B14-pathogens-09-00175]\] concluded that highly divergent β-tubulin paralogs existed in the genomes of FIESC, which excludes the use of this locus for FIESC phylogenetic inference. The high similarity of ITS (internally transcribed spacer region, ITS1-5.8S-ITS2) sequences (\>98%) also disqualifies this marker for phylogenetic demarcation of members of this species complex. The identification of FIESC isolates in Trinidad for the 2010-2014 survey was based on *EF-1*α and ITS sequence comparisons in the *FUSARIUM*-ID database \[[@B8-pathogens-09-00175]\]. There is a lack of Latin binomials for most of the species within the FIESC and presents systematic challenges in terms of taxonomic demarcation for this complex, which was initially based on homoplastic morphological characters and ITS sequence comparisons. Therefore, the present study sought to confirm and expand the identities of the *Fusarium* isolates infecting bell pepper in Trinidad in a re-sampling effort using a three-locus MLST scheme and up-to-date phylogenetic species identities provided by *Fusarium* MLST (<http://www.wi.knaw.nl/Fusarium/>). Accurate species assignment is important for epidemiological studies and guiding disease management.

Chemical control using methyl benzimidazole carbamates (MBCs) \[FRAC code: 1\] is the main approach to disease management in bell peppers in Trinidad. MBCs function to disrupt β-tubulin monomerization, which, in turn, affects microtubule arrangement and mitotic spindle formation \[[@B20-pathogens-09-00175]\]. Ramdial et al. \[[@B21-pathogens-09-00175]\] indicated that, in Trinidad, resistance to MBCs was detected in the *C. truncatum* population infecting bell pepper fruit and that FIESC isolates had significantly lower EC50 values compared to *C. truncatum*. However, it was unclear whether these EC50 values for FIESC isolates reflected resistance or dosage requirements for this fungicide. FRAC \[[@B22-pathogens-09-00175]\] warns of a high risk of resistance, resulting from the over-use of benzimidazoles and resistance management is an important consideration for controlling diseases caused by *Fusarium* species, e.g., *F. graminearum*, *F. oxysporum* f. sp. *gladioli* and *F. oxysporum* f. sp. *lilli* \[[@B23-pathogens-09-00175],[@B24-pathogens-09-00175],[@B25-pathogens-09-00175],[@B26-pathogens-09-00175]\]. Alternatives to benzimidazole fungicides to control fungal diseases in bell pepper in Trinidad are necessary to reduce the risk of MBC fungicide resistance in the FIESC pathogen population. Recent research on the differences in antifungal susceptibility between species and isolates also demonstrates the need for correct species-level identification \[[@B15-pathogens-09-00175]\].

Azoles are the largest, most commercially successful class of sterol 14α-demethylation inhibiting (DMI) fungicides \[FRAC code: 3\], and there is a wide variation in the activity spectra of different DMI fungicides \[[@B22-pathogens-09-00175],[@B27-pathogens-09-00175]\]. Sterol 14α-demethylase is required for sterol biosynthesis in fungi and is also the target of azole compounds that inhibit ergosterol biosynthesis in fungi, which halts fungal growth as a result of dysregulation of fluidity, permeability, and rigidity of fungal plasma membranes \[[@B28-pathogens-09-00175],[@B29-pathogens-09-00175],[@B30-pathogens-09-00175],[@B31-pathogens-09-00175],[@B32-pathogens-09-00175],[@B33-pathogens-09-00175]\]. Rapid market growth for triazole fungicides has been reported for North America, Europe, and the Asia Pacific, while in the UK, the Netherlands, and Denmark, prothioconazole, epoxiconazole, and tebuconazole are the main azole fungicides used in crop production \[[@B34-pathogens-09-00175]\]. Although tebuconazole consists of a pair of enantiomers that results in apparent enantioselective fungicidal activity, uptake and translocation \[[@B35-pathogens-09-00175],[@B36-pathogens-09-00175]\], it is among the most commonly used fungicides to control *F. graminearum* and *Fusarium* head blight diseases of wheat in many countries \[[@B37-pathogens-09-00175],[@B38-pathogens-09-00175]\].

Azole fungicides inhibit sterol substrate binding and, therefore, function to inhibit cytochrome P450 sterol 14 α-demethylase CYP51 enzyme activity. CYP51 genes encode sterol 14α-demethylases, which appear to retain strict catalytic function in the oxidative removal of the 14α-methyl group from sterol precursors across all phyla \[[@B39-pathogens-09-00175]\]. Three CYP51 paralogues have been described for *Fusarium* species, of which CYP51C is unique to this genus \[[@B40-pathogens-09-00175]\]. In a study of *F. graminearum* isolates by Fan et al. \[[@B41-pathogens-09-00175]\], *Fg*CYP51C served as a virulence factor and can indirectly affect sterol 14α-demethylation even though it no longer functions as a sterol 14α-demethylase and where deletion of *Fg*CYP51C, either as single or double mutants (*ΔFg*CYP51AC), had no effect on azole sensitivity, which suggested that CYP51C is a neo-functionalized paralogue. Conversely, in a separate study by Liu et al. \[[@B42-pathogens-09-00175]\] also of *F. graminearum* isolates, there was increased sensitivity to tebuconazole and prochloraz in *ΔFg*CYP51C mutants. *Fusarium* can engage a number of other virulence factors that function as specialized genes or as part of complex pathways \[[@B43-pathogens-09-00175],[@B44-pathogens-09-00175],[@B45-pathogens-09-00175],[@B46-pathogens-09-00175],[@B47-pathogens-09-00175],[@B48-pathogens-09-00175],[@B49-pathogens-09-00175]\]. The paucity of information regarding evolutionary maintenance of this CYP51C paralogue and conflicting evidence concerning its involvement in azole resistance indicates that these relationships should be examined for the following reasons: (i) azoles are among the main fungicides used in crop production worldwide, (ii) cross-resistance between agricultural and clinical azoles impact on opportunistic fusaria that cause diseases in humans and animals, and (iii) alternative approaches to avoid or delay azole resistance may include the inhibition of CYP51 with substrate analogs, however, without data on the genetic structure of CYP51C in relation to azole resistance or tolerance, this strategy remains incomplete.

The main objectives of this study were, therefore, to (i) identify members of FIESC to the phylogenetic species level and clarify the phylogenetic relationships among FIESC sequences from Trinidad and other geographical regions using a three-locus sequence comparison approach, (ii) determine the sensitivity of Trinidad FIESC isolates to tebuconazole based on in vitro bioassays, and (iii) examine CYP51C genetic structure for correlation with azole fungicide sensitivity. This data is important to different research communities, including those studying *Fusarium* phytopathology, mycotoxins, and public health impacts.

2. Results {#sec2-pathogens-09-00175}
==========

2.1. The Identification and Phylogenetic Placement of Isolates {#sec2dot1-pathogens-09-00175}
--------------------------------------------------------------

The three-locus dataset consisted of concatenated *EF-1α*, *CAM*, and *RPB2* partial gene sequences based on their demonstrated phylogenetic informativeness within the genus (GenBank Accession Nos. MN729351 to MN729362). Reference sequence data used to construct phylogenetic trees is detailed in [Table 1](#pathogens-09-00175-t001){ref-type="table"}. Phylogenetic analyses identified three different MLST haplotypes of *F. incarnatum* indicative of three phylogenetic species and one MLST group of *F. equiseti* indicative of just one phylogenetic species. The *F. incarnatum* membership species were FIESC-15a, FIESC-16a, and FIESC-26a. The *F. equiseti* membership species could not be determined as the Trinidad isolates clustered separately with high bootstrap support from all other Equiseti species, but was confirmed to be a member species of the Equiseti clade. These four Trinidad *F. equiseti* isolates represented 8% of the total number of isolates that were subjected to genetic typing. The remaining Trinidad isolates belonged to the Incarnatum clade as phylogenetic species FIESC-15a (22%), FIESC-16a (48%), and FIESC-26a (22%) and these sequences were resolved for each individual locus. Bootstrapping of the three-gene concatenated dataset provided strong support for several distinct relationships among the MLST haplotypes of FIESC and enabled the identification of *F. equiseti* species that, phylogenetically, may be new to the already known haplotypes ([Figure 1](#pathogens-09-00175-f001){ref-type="fig"}).

2.2. Tebuconazole Phenotypes {#sec2dot2-pathogens-09-00175}
----------------------------

Representative isolates from each group were selected for fungicide screens: *F. incarnatum*: FIESC-15a (N = 9); FIESC-16a (N = 21); FIESC-26a (N = 12) and *F. equiseti* (N = 4) ([Table 2](#pathogens-09-00175-t002){ref-type="table"}; [Table 3](#pathogens-09-00175-t003){ref-type="table"}). EC50 values were significantly different among the MLST groups (*p* ≤ 0.001). Tukey (HSD) and LSD (T) comparisons of EC50 values revealed two homogeneous groups: one group consisted of isolates belonging to *F. equiseti* and FIESC-26a, and the other group consisted of isolates belonging to FIESC-15a and FIESC-16a. The EC50 values of isolates between these two groups were significantly different (*p* ≤ 0.01); however, there were no significant differences in EC50 values within *F. equiseti* and FIESC-26a, *p* = 0.6879; and within FIESC-15a and FIESC-16a, *p* = 0.4059 ([Supplementary data file 1: Statistical analysis---Tables S1 and S2 (a--e)](#app1-pathogens-09-00175){ref-type="app"}). FIESC isolates demonstrated one of two phenotypes: "less sensitive" to 10 µg/mL tebuconazole (isolates belonging to FIESC-15a and FIESC-16a), and "more sensitive" to 10 µg/mL tebuconazole (FIESC-26a and *F. equiseti*).

2.3. CYP51C Sequence Analysis {#sec2dot3-pathogens-09-00175}
-----------------------------

Analysis of the conservation plot of the aligned FIESC CYP51C nucleotide sequences from the Trinidad isolates revealed five polymorphic sites: nt position 51 C \> T; nt position 69 A \> G; nt position 221 T \> G; nt position 423 A \> G; nt position 647 C \> T. All other sites were highly conserved for all isolates included in the dataset. Haplotype analysis revealed five CYP51C haplotypes (h = 5). Haplotype 1 was shared by twenty-seven isolates; haplotype 2 was shared by two isolates, 31 and 36; haplotype 3 was shared by the nine isolates of the second cluster; haplotype 4 was shared by two isolates, 38 and 49; haplotype 5 was shared by two isolates 13 and 14. Haplotype diversity (Hd) for the aligned CYP51C gene sequences was 0.540, and low estimates are \<0.5. There were no recombination footprints for the FIESC CYP51C sequences of the Trinidad isolates based on Hudson's r estimation of the recombination rate per sequence or per site in DnaSP. RDP3 also did not detect any signatures of recombination. The nonsynonymous/synonymous substitution sites ratio, dN/dS ratio, was \>1 (value = 3.46), which suggested that the sequences were under positive selection \[[@B52-pathogens-09-00175]\]. CYP51C nucleotide and deduced amino acid sequence had no correlation to azole sensitivity in this study.

Phylogenetic analysis of CYP51C sequences was carried out on a final sequence dataset of 81 nucleotide sequences. Phylogenetic inference revealed polytomic branching for 41 FIESC Trinidad isolates with the other reference FIESC sequences, which is illustrated as a collapsed branch in the ML tree. The majority of reference *Fusarium* sequences were resolved into distinct, species-specific clusters ([Figure 2](#pathogens-09-00175-f002){ref-type="fig"}), indicating that CYP51C sequences may have species-specific signatures that are absent among members of FIESC as a species complex and explains why FIESC sequences could not be resolved.

3. Discussion {#sec3-pathogens-09-00175}
=============

Members of FIESC from Trinidad were identified to the phylogenetic species level but only for the Incarnatum clade membership. Three Incarnatum species, FIESC-15a, FIESC-16a, and FIESC-26a, and one Equiseti species, were identified based on a three-locus sequence comparison scheme. *EF-1*α, *RPB2*, and *CAM* markers were successful in resolving the Trinidad *F. incarnatum* isolates. Other studies reported that the *CAM* and *RPB2* gene sequences were more successful at identifying isolates within the FCSC and FIESC associated with human and animal infections \[[@B14-pathogens-09-00175],[@B53-pathogens-09-00175]\]. Conversely, it was found that the *RPB2* locus was less discriminatory than *EF-1*α sequences in a study of 25 clinical isolates in China \[[@B54-pathogens-09-00175]\]. The results of the three-locus DNA typing scheme discussed herein extend and provide additional data on the species/species complex distribution and genetic diversity of major pathogenic FIESC isolates, which was previously based on one locus (*EF-1*α) as the ITS sequences were not phylogenetically informative \[[@B8-pathogens-09-00175]\]. While partial sequences of *EF-1*α have proven to be extraordinarily useful for resolving species boundaries in *Fusarium* \[[@B18-pathogens-09-00175],[@B55-pathogens-09-00175],[@B56-pathogens-09-00175],[@B57-pathogens-09-00175],[@B58-pathogens-09-00175]\], most of the intronic sequences are too divergent to align beyond the species complex. For this reason, *RPB1* and *RPB2* nucleotide sequences are more informative for genus-wide phylogenetics within *Fusarium*. However, in this study, *CAM* and *RPB2* nucleotide sequences were unable to assign Trinidad Equiseti isolates to MLST haplotype within the Equiseti clade. Additional loci of *GAPDH* and *ACT* nucleotide sequences were also unable to resolve Trinidad Equiseti isolates to MLST haplotype (data not shown).

To date, considerable effort has been expended to devise accurate approaches to molecular phylogenetic analysis of *Fusarium* species. Depending on the species and the species complex, different combinations of markers whereby the locus and the number of markers must enable species-specific sequence identification \[[@B53-pathogens-09-00175]\]. A single-locus (*EF-1*α gene) best match at \<99.4% sequence identity indicates that this query species may not be represented in the database for this locus and, therefore, sequence data from additional loci are recommended to identify phylogenetic species accurately \[[@B53-pathogens-09-00175]\]. Two loci, *EF-1*α and RBP2, allow species identification within the *Gibberella* (*Fusarium fujikuroi*) species complex GFSC, but for *F. oxysporum* species complex (FOSC), the loci recommended are *EF-1*α and IGS \[[@B14-pathogens-09-00175]\]. To discriminate among cryptic species within the *Fusarium solani* species complex (FSSC), FIESC, and *F. chlamydosporum* species complex (FCSC), ≥four loci are recommended: *EF-1*α, *CAM*, *RPB2*, ITS \[[@B53-pathogens-09-00175]\].

Generally, species delimitation within the FIESC is still poorly defined. Within the *Fusarium incarnatum-equiseti* species complex (FIESC) and using multiple loci, at least 33 species can be recognized, which are organized into two main clades: MLST haplotypes 1--14 are molecular siblings of *F. equiseti*, while the remaining MLST haplotypes are grouped as '*F. incarnatum*' \[[@B14-pathogens-09-00175]\]. Species assignment within the Equiseti clade, according to Wang et al. \[[@B59-pathogens-09-00175]\] includes: *F. ipomoeae*-FIESC-1; *F. compactum*-FIESC-3; *F. equiseti*, *F. incarnatum*, *F. lacertarum*-FIESC-4; *F. arcuatisporum*-FIESC-7; *F. scirpi*-FIESC-9; and *F. equiseti*-FIESC-14. The Incarnatum clade consists of: *F. irregulare*-FIESC-15; *F. sulawense*-FIESC-16/-17; *F. luffe*-FIESC-18; *F. guillinense*-FIESC-21; *F. nanum*-FIESC-25; *F. hainanense*-FIESC-26; *F. citri*-FIESC-29; and *F. humuli*-FIESC-33. However, these species may not be universally accepted in all indexes, for example, *F. scirpi* is currently listed as a synonym of *F. acuminatum* in the Index Fungorum (<http://www.indexfungorum.org/>), but is a distinct species in MycoBank (<http://www.mycobank.org/>).

Of the Incarnatum haplotypes detected in Trinidad, FIESC-15, identified as *F. irregulare*, is commonly associated with human infections in the USA; FIESC-16, identified as *F. sulawense*, is associated with both human and plant diseases including *Capsicum* species. FIESC-26, identified as *F. hainanense*, is associated with only plant diseases to date \[[@B59-pathogens-09-00175]\]. Observed fusarioses range from onychomycoses, skin infections, and keratitis, mainly in healthy individuals, to deep local and disseminated infections in immunocompromised, predominantly in leukemia patients with a high mortality rate. In general, like many other members of the order Hypocreales, *Fusarium* species are highly refractory to antifungal therapy. To reveal small differences in susceptibility between clinically relevant *Fusarium* species, precise identification of isolates is recommended \[[@B60-pathogens-09-00175]\]. This suggests that the detection of FIESC-15 and FIESC-16 Trinidad isolates may have clinical implications.

Since their introduction to agriculture over three decades ago, reduced sensitivity to azoles has been reported for several important phytopathogenic fungi, including *F. graminearum* \[[@B33-pathogens-09-00175],[@B61-pathogens-09-00175]\], *Erysiphe graminis* \[[@B62-pathogens-09-00175]\], *Monilinia fructicola* \[[@B63-pathogens-09-00175]\], and *Mycosphaerella graminicola* \[[@B64-pathogens-09-00175]\]. Three molecular mechanisms have been described that may explain a "less sensitive" or "less resistant" phenotype against azole fungicides \[[@B34-pathogens-09-00175],[@B65-pathogens-09-00175],[@B66-pathogens-09-00175],[@B67-pathogens-09-00175],[@B68-pathogens-09-00175],[@B69-pathogens-09-00175]\]. The azoles used in agriculture and in clinical settings target the same active site, which means that pathogenic fungi can engage shared modes of resistance \[[@B70-pathogens-09-00175]\]. Faria-Ramos et al. \[[@B71-pathogens-09-00175]\] and Berger et al. \[[@B72-pathogens-09-00175]\] reported the resistance of *Aspergillus* sp. to clinically relevant azole fungicides was due to exposure to agricultural azoles which led to the emergence of cross-resistance.

Our findings indicated that, for field isolates of FIESC in Trinidad, there was an association between specific phylogenetic species and tebuconazole sensitivity. FIESC-26a and *F. equiseti* species were sensitive to 10 µg/mL of tebuconazole fungicide as a discriminatory dose in in vitro bioassays. In this study, there was no correlation between tebuconazole sensitivity and CYP51C haplotypes. A study of *Rhynchosporium commune* isolates in the UK revealed similar findings where the CYP51B gene: (i) was under positive selection, (ii) had no signatures of recombination, (iii) had little nucleotide diversity, and (iv) neither amino acid sequence nor haplotypes were associated with azole sensitivity \[[@B73-pathogens-09-00175]\]. It is proposed that in such cases, the paralogue acquired and retained a function that was different from the ancestral type but was one that enabled evolutionary adaptation and survival of pathogenic fungi.

The CYP51C gene was present in all FIESC isolates included in this study; however, while five polymorphic sites were found in the aligned nucleotide sequences of the Trinidad isolates, there was absolute amino acid conservation. This low level of diversity, together with evidence of positive selection for the CYP51C gene and a polytomic phylogenetic relationship, indicate that CYP51C is a conserved functional paralogue among these FIESC isolates and it is under selective constraints. Not all CYP51 gene duplications result in functional conservation of the copied gene, for example, Hawkins et al. \[[@B74-pathogens-09-00175]\] reported the existence of two paralogues of CYP51 gene in *R. commune*: CYP51A, CYP51B and a duplicated copy of CYP51A considered to be a pseudogene (CYP51A-p) because of its high nucleotide sequence diversity, it was not under purifying selection and was not functional. Paralogues tend to persist in a given genome when one of two paralogues undergo positive selection due to gain a novel function (neofunctionalization), while the other paralogue preserves the ancestral function or where the paralogues partition the ancestral function \[[@B75-pathogens-09-00175],[@B76-pathogens-09-00175],[@B77-pathogens-09-00175]\].

There are increasing reports of plant pathogenic *Fusarium* species implicated in opportunistic and systemic infections in humans and animals, which suggests that these Fusaria are able to engage pathogenic strategies to infect plants as well as animals and humans \[[@B78-pathogens-09-00175]\]. This trans-kingdom pathogenicity may be due to a number of virulence factors which perhaps include CYP51C.

4. Materials and Methods {#sec4-pathogens-09-00175}
========================

4.1. Collection of Isolates {#sec4dot1-pathogens-09-00175}
---------------------------

Bell pepper fields located in the main growing areas in Trinidad were visited: Aranguez (north and south), Orange Grove, Maloney, Caura, Caroni, Bon aventure, Penal, Mayo. Red bell pepper fruits showing typical symptoms of FIESC infection were collected in plastic bags and were transported to the lab. Symptoms of infection included large watery lesions that expanded to the calyx end of the fruit with internal rot of the seed placenta in severely infected fruit. The fruits were surface sterilized by rinsing in 70% ethanol for 1 min followed by another rinse in 0.6% sodium hypochlorite solution for 1 min. Samples were then washed three times in sterilized distilled water and air-dried. Blocks of fruit tissue (5 mm^3^) were removed from the margins of the lesions and transferred to potato dextrose agar (PDA) media (Oxoid Ltd., UK) supplemented with 50 mg/L streptomycin, tetracycline, and chloramphenicol. Plates were incubated for seven days in the dark at 25 °C. Monoconidial cultures were subsequently obtained and maintained on PDA at 4 °C for temporary storage, and as conidial suspensions in 50% glycerol at −70 °C for long-term storage. The number of isolates according to field location were as follows: Aranguez (N = 12); Macoya (N = 27); Maloney (N = 19); Central (N = 6); Penal (N = 5); Bon Aventure (N = 10).

4.2. DNA Extraction, PCR Amplification, and Sequencing {#sec4dot2-pathogens-09-00175}
------------------------------------------------------

DNA was extracted from actively growing colonies using the Maxwell^®^-16 automated DNA extraction system (Promega, Madison, Wisconsin, USA) based on magnetic bead capture DNA extraction according to the manufacturer's instructions. The *EF-1*α gene of 50 isolates in the Trinidad collection was amplified using published protocols \[[@B14-pathogens-09-00175],[@B55-pathogens-09-00175],[@B79-pathogens-09-00175]\]. PCR products were sequenced directly (MCLAB, San Francisco, USA). Nucleotide sequences were aligned using MAFFT (Multiple Alignment using Fast Fourier Transform) alignment programs (<https://www.ebi.ac.uk/Tools/msa/mafft/>; \[[@B80-pathogens-09-00175]\]). Sequences were then edited using BioEdit sequence alignment editor software version 7.2.5 (<http://www.mbio.ncsu.edu/bioedit/page2.html>). A homology search was carried out for the *EF-1*α sequences in *Fusarium* MLST \[[@B14-pathogens-09-00175],[@B53-pathogens-09-00175]\].

4.3. Multi-locus Sequencing Typing (MLST) for Phylogenetic Species Identification {#sec4dot3-pathogens-09-00175}
---------------------------------------------------------------------------------

Species designations were based on the multi-locus haplotype system of O' Donnell et al. \[[@B14-pathogens-09-00175]\]. Arabic numerals were used to assign isolates to phylogenetic species, and lowercase Roman letters were used to indicate a \>99.4% sequence match to the unique haplotype in the *Fusarium* MLST database. Partial sequences of three gene regions were used: *EF-1α* (598 bp) \[[@B79-pathogens-09-00175]\], *RPB2* (primers: *RPB2*-5f2 and *RPB2*-7cr, amplicon size 1750 bp) \[[@B53-pathogens-09-00175]\] and *CAM* (primers CL1 and CL2, amplicon size 700 bp) \[[@B81-pathogens-09-00175]\]. Thermal cycling conditions for amplifying *EF-1α* and *RPB2* were carried out as described by O'Donnell et al. \[[@B53-pathogens-09-00175],[@B79-pathogens-09-00175]\]. Amplification of the *CAM* gene region was as described by Cai et al. \[[@B81-pathogens-09-00175]\] and Prihastuti et al. \[[@B82-pathogens-09-00175]\]. The specific gene regions and the number of loci used for MLST were determined according to the study by O'Donnell et al. \[[@B14-pathogens-09-00175]\]. A three-locus scheme allowed for more robust genetic typing. Twenty representative isolates were used in sequence comparisons of *RPB2* and *CAM* gene regions based on the homology search to identify *EF-1*α sequences in *Fusarium* MLST. Two additional loci were amplified according to the PCR conditions described by Prihastuti et al. \[[@B82-pathogens-09-00175]\], Actin (*ACT*; Primers: ACT512F 5′-ATGTGCAAGGCCGGTTTCGC-3′ and ACT783R 5′-TACGAGTCCTTCTGGCCCAT-3′) \[[@B82-pathogens-09-00175]\] and Glyceradehyde-3-phosphate dehydrogenase (*GAPDH*; Primers: GAPDHF1 5′-GCCGTCAACGACCCCTTCATTGA3′ and GDR1 5′-GGGTGGAGTCGTACTTGAGCATGT-3′) \[[@B82-pathogens-09-00175]\] and the amplicons were sequenced. However, these sequences are not curated in the CBS-KNAW culture collection, and BLASTn searches in GenBank indicated assignment only to the genus level and not to FIESC phylogenetic species level. Therefore, these *ACT* and *GAPDH* sequences were omitted from the final MLST scheme.

4.4. Phylogenetic Analysis {#sec4dot4-pathogens-09-00175}
--------------------------

For each locus, sequences were aligned using the MAFFT v. 7 (Multiple Alignment using Fast Fourier Transform) \[[@B80-pathogens-09-00175]\], and the alignments were manually adjusted in BioEdit \[[@B83-pathogens-09-00175]\]. Phylogenetic relationships of both individual gene and concatenated gene datasets were inferred by the maximum likelihood (ML) algorithm using MEGA6 (<https://www.megasoftware.net/>) \[[@B51-pathogens-09-00175]\] and PhyML v.3.0 (<http://www.atgc-montpellier.fr/phyml/>) \[[@B84-pathogens-09-00175]\] software. The best fit model of nucleotide substitution for each locus was determined in MEGA6 by examining the Bayesian and Akaike criterion information scores, as well as the log-likelihood scores. Kimura-2-Parameter (K-2-P+G/I) was found to be the simplest best fit model for each locus. A more complex model was also applied (GTR+G+I) for each locus to compare branching, taxon placement, and bootstrap scores in phylogenetic trees generated with the K-2-P+G model. Non-uniformity of evolutionary rates among sites were compensated for by using a discrete Gamma distribution (+G) with five rate categories with the assumption that a proportion of sites are evolutionarily invariable (+I). The parameters were the same for both models, and therefore, the GTR+G+I model was used for the concatenated data. Bootstrap values over 75% were considered significant and, therefore, the rooted, 75% consensus tree is presented. Sequences of the *EF-1*α, *RPB2* and *CAM* datasets of O'Donnell et al. \[[@B14-pathogens-09-00175]\] were used in phylogenetic analyses: FIESC *EF-1*α PopSet: 262476356, FIESC *RPB2* PopSet: 262476623, FIESC *CAM* PopSet: 262476268.

4.5. Fungicide Sensitivity {#sec4dot5-pathogens-09-00175}
--------------------------

The sensitivity of FIESC isolates to tebuconazole was assessed in an in vitro radial mycelial growth assay. The PDA media were amended with 0.0, 0.1, 1.0, 10.0, and 100.0 μg/mL of a commercial formulation of the fungicide ("Tebizole-25% WP"-Veterinary and agricultural products manufacturing company Ltd., Jordan, Israel). Stock solutions of the fungicide were prepared in acetone, and an acetone-only control was included \[[@B85-pathogens-09-00175]\]. The commercial fungicide preparation was insoluble in sterile distilled water. Four replicates of each fungicide concentration were used for each isolate, and the experiment was performed twice. Blocks (4-mm^3^) were moved from the advancing edge of actively growing colonies and placed, mycelium-side down, in the center of fungicide amended medium. The plates were incubated at 25 °C for five days, and the radial diameter of each colony was measured (orthogonal measurements) for each isolate to determine the percentage of relative growth inhibited compared to the growth on non-amended media. The measurement data for both replicates did not differ significantly based on Fisher's Least Significant Difference Test (LSD) at *p* ≤ 0.05. Mean diameter values were, therefore, used in subsequent analyses. Linear regression analysis of the percentage of growth inhibition (mycelia growth of the control versus the log10 of the fungicide concentration) was carried out in MINITAB v.17 (State College, PA, USA). The effective concentration required to achieve 50% colony growth inhibition (EC50) on fungicide-amended media was calculated for isolates according to MLST. The DMI fungicides have no effect on spore germination and early germ tube growth because of sterol reserves in spores \[[@B86-pathogens-09-00175]\]; therefore, the effect of tebuconazole on spore germination was not investigated here.

4.6. Genetic Structure of CYP51C {#sec4dot6-pathogens-09-00175}
--------------------------------

CYP51C sequences were amplified by primers designed by Fernández-Ortuño et al. \[[@B87-pathogens-09-00175]\]. Sequencing was done as described in the previous section. Nucleotide sequences were aligned with the MAFFT alignment program with manual sequence adjustments in BioEdit. The final alignment consisted of 81 CYP51C sequences: 41 sequences belonged to FIESC Trinidad, and the other 40 belonged to PopSet: 292660854 \[[@B87-pathogens-09-00175]\].

The relative degree of DNA polymorphism, nucleotide divergence, and haplotype analysis were determined for CYP51C nucleotide sequences using DnaSP (DNA Sequence Polymorphism software version 5.10) \[[@B88-pathogens-09-00175],[@B89-pathogens-09-00175]\]. DnaSP software was also used to determine whether CYP51C sequences were under positive selection and to find evidence of recombination. RDP3 software was used for characterizing recombination events, visualizing patterns of recombination, and recombination-aware ancestral sequence reconstruction. The CYP51C nucleotide sequences were translated using the EMBOSS Transeq software (<https://www.ebi.ac.uk/Tools/st/emboss_transeq/>) and aligned using Clustal Omega (<https://www.ebi.ac.uk/Tools/msa/clustalo/>). The amino acid alignment was edited, and the conservation plot was analyzed in BioEdit. Phylogenetic analysis was carried out as previously described.

The authors wish to thank Stephen Narine and Sumair Mahabir for field assistance.

The following are available online at <https://www.mdpi.com/2076-0817/9/3/175/s1>, Table S1: Summary statistics for percentage growth inhibition; Table S2: Summary statistics for EC50 data.
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###### 

(**A**,**B**). Phylogenetic analysis of FIESC sequences based on concatenated partial nucleotide sequences of *EF-1α*, *RPB2*, and *CAM* genes. The phylogenetic relationships were inferred by using the Maximum Likelihood method based on the General Time Reversible model, as the best fit model, with 1000 bootstrapped replicates \[[@B50-pathogens-09-00175]\]. The tree with the highest log-likelihood is shown. The percentage of trees in which the associated taxa clustered together is shown next to the branches. The tree is drawn to scale, with branch lengths measured in the number of substitutions per site. The analysis involved 103 nucleotide sequences. All positions containing gaps and missing data were eliminated. There were a total of 1804 positions in the final dataset. Evolutionary analyses were conducted in MEGA6 \[[@B51-pathogens-09-00175]\]. Black triangle depicts a collapsed branch; blue boxes indicate sequences belonging to a confirmed FIESC haplotype; green box indicates unresolved Trinidad Equiseti sequences.
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![Phylogenetic analysis of CYP51C partial gene sequences of FIESC isolates from Trinidad and other geographical regions by Maximum Likelihood method based on the General Time Reversible model, as the best fit model, with 1000 bootstrapped replicates \[[@B50-pathogens-09-00175]\]. The tree with the highest log-likelihood is shown. The tree is drawn to scale, with branch lengths measured in the number of substitutions per site. The analysis involved 81 nucleotide sequences. All positions containing gaps and missing data were eliminated. There was a total of 259 positions in the final dataset. Evolutionary analyses were conducted in MEGA6 \[[@B51-pathogens-09-00175]\].](pathogens-09-00175-g002){#pathogens-09-00175-f002}
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###### 

Reference sequences used in the phylogenetic study.

  *CAM*      *EF1a*     *RPB2*     NRRL    FIESC Haplotype   Host                         Country        Reference
  ---------- ---------- ---------- ------- ----------------- ---------------------------- -------------- -------------------------------
  GQ505575   GQ505664   GQ505482   43637   1-a               dog                          Pennsylvania   \[[@B14-pathogens-09-00175]\]
  GQ505582   GQ505671   GQ505849   45996   1-a               human sinus                  New York       \[[@B14-pathogens-09-00175]\]
  GQ505578   GQ505667   GQ505845   43640   1-a               dog nose                     Texas          \[[@B14-pathogens-09-00175]\]
  GQ505551   GQ505639   GQ505817   34039   1-b               human                        Connecticut    \[[@B14-pathogens-09-00175]\]
  GQ505548   GQ505636   GQ505814   34034   1-c               human leg                    Arizona        \[[@B14-pathogens-09-00175]\]
  GQ505563   GQ505651   GQ505829   36401   2-a               cotton                       Mozambique     \[[@B14-pathogens-09-00175]\]
  GQ505564   GQ505652   GQ505830   36448   2-b               *Phaseolus vulgaris* seed    Sudan          \[[@B14-pathogens-09-00175]\]
  GQ505824   GQ505646   GQ505558   36318   3-a               unknown                      unknown        \[[@B14-pathogens-09-00175]\]
  GQ505560   GQ505648   GQ505826   36323   3-a               cotton yarn                  England        \[[@B14-pathogens-09-00175]\]
  GQ505514   GQ505602   GQ505780   28029   3-b               Human eye                    California     \[[@B14-pathogens-09-00175]\]
  GQ505505   GQ505593   GQ505771   20423   4-a               Lizard skin                  India          \[[@B14-pathogens-09-00175]\]
  GQ505555   GQ505643   GQ505821   36123   4-b               unknown                      unknown        \[[@B14-pathogens-09-00175]\]
  GQ505531   GQ505619   GQ505797   32871   5-a               human abscess                Texas          \[[@B14-pathogens-09-00175]\]
  GQ505547   GQ505635   GQ505813   34032   5-a               human abscess                Texas          \[[@B14-pathogens-09-00175]\]
  GQ505550   GQ505638   GQ505816   34037   5-b               human abscess                Colorado       \[[@B14-pathogens-09-00175]\]
  GQ505581   GQ505670   GQ505848   45995   5-b               human abscess                Colorado       \[[@B14-pathogens-09-00175]\]
  GQ505509   GQ505597   GQ505775   25795   5-c               *Disphyma* seed              Germany        \[[@B14-pathogens-09-00175]\]
  GQ505549   GQ505637   GQ505815   34035   5-d               human sinus                  Colorado       \[[@B14-pathogens-09-00175]\]
  GQ505572   GQ505661   GQ505839   43623   5-e               human maxillary sinus        Colorado       \[[@B14-pathogens-09-00175]\]
  GQ505583   GQ505672   GQ505850   45997   5-f               human sinus                  Colorado       \[[@B14-pathogens-09-00175]\]
  GQ505576   GQ505665   GQ505843   43638   6-a               Manatee                      Florida        \[[@B14-pathogens-09-00175]\]
  GQ505579   GQ505668   GQ505846   43694   6-a               human eye                    Texas          \[[@B14-pathogens-09-00175]\]
  GQ505584   GQ505673   GQ505851   45998   6-b               human toe                    Texas          \[[@B14-pathogens-09-00175]\]
  GQ505536   GQ505642   GQ505802   32997   7-a               human toe nail               Colorado       \[[@B14-pathogens-09-00175]\]
  GQ505500   GQ505588   GQ505766   5537    8-a               Fescue hay                   Missouri       \[[@B14-pathogens-09-00175]\]
  N/A        GQ505658   GQ505836   43498   8-b               human eye                    Pennsylvania   \[[@B14-pathogens-09-00175]\]
  GQ505566   GQ505654   GQ505832   36478   9-a               Pasture soil                 Australia      \[[@B14-pathogens-09-00175]\]
  GQ505517   GQ505604   GQ505783   29134   9-a               Pasture soil                 Australia      \[[@B14-pathogens-09-00175]\]
  GQ505504   GQ505592   GQ505770   13402   9-b               Pine soil                    Australia      \[[@B14-pathogens-09-00175]\]
  GQ505513   GQ505601   GQ505779   26922   9-c               soil                         France         \[[@B14-pathogens-09-00175]\]
  GQ505498   GQ505586   GQ505764   3020    10-a              unknown                      unknown        \[[@B14-pathogens-09-00175]\]
  GQ505499   GQ505587   GQ505765   3214    10-a              unknown                      unknown        \[[@B14-pathogens-09-00175]\]
  GQ505561   GQ505649   GQ505827   36372   11-a              air                          Netherlands    \[[@B14-pathogens-09-00175]\]
  GQ505501   GQ505589   GQ505767   6548    12-a              Wheat                        Germany        \[[@B14-pathogens-09-00175]\]
  GQ505512   GQ505600   GQ505778   26921   12-a              Wheat                        Germany        \[[@B14-pathogens-09-00175]\]
  GQ505518   GQ505606   GQ505784   31011   12-a              *Thuja* sp.                  Germany        \[[@B14-pathogens-09-00175]\]
  GQ505557   GQ505645   GQ505823   36269   12-b              *Pinusnigra* seedling        Croatia        \[[@B14-pathogens-09-00175]\]
  GQ505562   GQ505650   GQ505828   36392   12-c              seedling                     Germany        \[[@B14-pathogens-09-00175]\]
  GQ505573   GQ505662   GQ505840   43635   13-a              horse                        Nebraska       \[[@B14-pathogens-09-00175]\]
  GQ505511   GQ505599   GQ505777   26419   14-a              soil                         Germany        \[[@B14-pathogens-09-00175]\]
  GQ505556   GQ505644   GQ505822   36136   14-a              unknown                      unknown        \[[@B14-pathogens-09-00175]\]
  GQ505559   GQ505647   GQ505825   36321   14-a              soil                         Netherlands    \[[@B14-pathogens-09-00175]\]
  GQ595565   GQ505653   GQ505831   36466   14-a              potato peel                  Denmark        \[[@B14-pathogens-09-00175]\]
  GQ505506   GQ505594   GQ505772   20697   14-b              beet                         Chile          \[[@B14-pathogens-09-00175]\]
  GQ505574   GQ505663   GQ505841   43636   14-c              dog                          Texas          \[[@B14-pathogens-09-00175]\]
  GQ505521   GQ505609   GQ505787   32175   15-a              human septum                 Texas          \[[@B14-pathogens-09-00175]\]
  GQ505542   GQ505630   GQ505808   34006   15-a              human eye                    Texas          \[[@B14-pathogens-09-00175]\]
  GQ505543   GQ505631   GQ505809   34007   15-a              human septum                 Texas          \[[@B14-pathogens-09-00175]\]
  GQ505546   GQ505634   GQ505812   34011   15-a              human septum                 Texas          \[[@B14-pathogens-09-00175]\]
  GQ505570   GQ505659   GQ505837   43619   15-a              human finger                 Texas          \[[@B14-pathogens-09-00175]\]
  GQ505523   GQ505611   GQ505789   32182   15-b              human blood                  Texas          \[[@B14-pathogens-09-00175]\]
  GQ505519   GQ505607   GQ505785   31160   15-c              human lung                   Texas          \[[@B14-pathogens-09-00175]\]
  GQ505522   GQ505610   GQ505788   32181   15-c              human blood                  Oklahoma       \[[@B14-pathogens-09-00175]\]
  GQ505530   GQ505618   GQ505796   32869   15-c              human cancer patient         Texas          \[[@B14-pathogens-09-00175]\]
  GQ505533   GQ505621   GQ505799   32994   15-c              human ethmoid sinus          Texas          \[[@B14-pathogens-09-00175]\]
  GQ505534   GQ505622   GQ505800   32995   15-c              human sinus                  Texas          \[[@B14-pathogens-09-00175]\]
  GQ505535   GQ505623   GQ505801   32996   15-c              human leg wound              Texas          \[[@B14-pathogens-09-00175]\]
  GQ505545   GQ505633   GQ505811   34010   15-c              human maxillary sinus        Texas          \[[@B14-pathogens-09-00175]\]
  GQ505571   GQ505660   GQ505838   43622   15-c              human lung                   Texas          \[[@B14-pathogens-09-00175]\]
  GQ505544   GQ505632   GQ505810   34008   15-d              human lung                   Texas          \[[@B14-pathogens-09-00175]\]
  GQ505537   GQ505625   GQ505803   34001   15-e              human foot wound             Texas          \[[@B14-pathogens-09-00175]\]
  GQ505540   GQ505628   GQ505806   34004   16-a              human BAL                    Texas          \[[@B14-pathogens-09-00175]\]
  GQ505552   GQ505640   GQ505818   34056   16-b              human bronchial wash         Illinois       \[[@B14-pathogens-09-00175]\]
  GQ505553   GQ505641   GQ505819   34059   16-c              human blood                  Illinois       \[[@B14-pathogens-09-00175]\]
  GQ505580   GQ505669   GQ505847   43730   16-c              Contact lens                 Mississippi    \[[@B14-pathogens-09-00175]\]
  GQ505525   GQ505613   GQ505791   32864   17-a              human                        Texas          \[[@B14-pathogens-09-00175]\]
  GQ505567   GQ505655   GQ505833   36548   17-b              Banana                       Congo          \[[@B14-pathogens-09-00175]\]
  GQ505554   GQ505642   GQ505820   34070   17-c              Tortoise                     Illinois       \[[@B14-pathogens-09-00175]\]
  GQ505520   GQ505608   GQ505786   31167   18-a              human septum                 Texas          \[[@B14-pathogens-09-00175]\]
  GQ505524   GQ505612   GQ505790   32522   18-b              human diabetic cellulitis    Illinois       \[[@B14-pathogens-09-00175]\]
  GQ505577   GQ505666   GQ505844   43639   19-a              Manatee                      Florida        \[[@B14-pathogens-09-00175]\]
  GQ505539   GQ505627   GQ505805   34003   20-a              human septum                 Texas          \[[@B14-pathogens-09-00175]\]
  GQ505568   GQ505656   GQ505834   36575   20-b              *Juniperus chinensis* leaf   Hawaii         \[[@B14-pathogens-09-00175]\]
  GQ505502   GQ505590   GQ505768   13335   21-a              alfalfa                      Australia      \[[@B14-pathogens-09-00175]\]
  GQ505526   GQ505614   GQ505792   32865   21-b              human endocarditis           Brazil         \[[@B14-pathogens-09-00175]\]
  GQ505538   GQ505626   GQ505804   34002   22-a              human ethmoid sinus          Texas          \[[@B14-pathogens-09-00175]\]
  GQ505527   GQ505615   GQ505793   32866   23-a              human cancer patient         Texas          \[[@B14-pathogens-09-00175]\]
  GQ505528   GQ505618   GQ505794   32867   23-a              human                        Texas          \[[@B14-pathogens-09-00175]\]
  GQ505503   GQ505591   GQ505769   13379   23-b              *Oryza sativa*               India          \[[@B14-pathogens-09-00175]\]
  GQ505541   GQ505629   GQ505807   34005   24-a              human intravitral fluid      Minnesota      \[[@B14-pathogens-09-00175]\]
  GQ505569   GQ505657   GQ505835   43297   24-b              *Saprotina* rhizomes         Connecticut    \[[@B14-pathogens-09-00175]\]
  GQ505508   GQ505596   GQ505774   22244   25-a              rice                         China          \[[@B14-pathogens-09-00175]\]
  GQ505532   GQ505620   GQ505798   32993   25-b              human nasal tissue           Texas          \[[@B14-pathogens-09-00175]\]
  GQ505529   GQ505617   GQ505795   32868   25-c              human blood                  Texas          \[[@B14-pathogens-09-00175]\]
  GQ505510   GQ505598   GQ505776   26417   26-a              leaf litter                  Cuba           \[[@B14-pathogens-09-00175]\]
  GQ505516   GQ505604   GQ505782   28714   26-b              *Acacia* sp. Branch          Costa Rica     \[[@B14-pathogens-09-00175]\]
  GQ505507   GQ505595   GQ505773   20722   27-a              *Chrysanthemum* sp.          Kenya          \[[@B14-pathogens-09-00175]\]
  GQ505515   GQ505603   GQ505781   28577   28-a              grave stone                  Romania        \[[@B14-pathogens-09-00175]\]
  GQ505585   GQ505674   GQ505852   13459   N/A               plant debris                 South Africa   \[[@B14-pathogens-09-00175]\]
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###### 

EC50 data for isolates belonging to FIESC-15a and FIESC-16a.

  Sample   MLST Type   Growth Inhibition (%) ^1^   EC50 (µg/mL)
  -------- ----------- --------------------------- --------------
  3        15-a        52.94                       9.1
  13       15-a        49.02                       10.4
  15       15-a        54.90                       7.8
  20       15-a        60.61                       5.5
  22       15-a        52.38                       9.5
  28       15-a        43.48                       13.3
  31       15-a        55.56                       7.7
  33       15-a        62.86                       4.7
  36       15-a        52.94                       9.1
  2        16-a        48.39                       10.1
  5        16-a        42.42                       13.8
  6        16-a        56.41                       7.2
  14       16-a        58.82                       6.3
  18       16-a        39.39                       10.8
  21       16-a        64.29                       4.3
  25       16-a        64.29                       4.3
  26       16-a        58.82                       6.4
  27       16-a        62.86                       4.7
  29       16-a        31.58                       18.4
  32       16-a        35.00                       17.1
  35       16-a        48.39                       10.9
  38       16-a        42.42                       13.8
  39       16-a        56.41                       7.7
  40       16-a        52.94                       8.7
  41       16-a        49.02                       10.5
  42       16-a        50.98                       11.5
  47       16-a        39.39                       10.8
  49       16-a        45.45                       5.5
  50       16-a        53.85                       12.4
  51       16-a        49.02                       10.5

^1^ Growth inhibition was determined for 10 µg/mL of tebuconazole.

pathogens-09-00175-t003_Table 3

###### 

EC50 data for isolates belonging to FIESC-26a and *Fusarium equiseti*.

  Sample   MLST Type   Growth Inhibition (%) ^1^   EC50 (µg/mL)
  -------- ----------- --------------------------- --------------
  56       26-a        80.00                       1.2
  57       26-a        82.05                       1.2
  58       26-a        80.00                       1.2
  59       26-a        80.56                       1.5
  60       26-a        81.58                       2.3
  61       26-a        80.56                       5.8
  62       26-a        80.00                       1.9
  63       26-a        80.00                       1.3
  64       26-a        80.00                       2.7
  65       26-a        80.00                       3.2
  66       26-a        80.56                       1.9
  67       26-a        80.00                       1.6
  52       Equiseti    100.00                      2.6
  53       Equiseti    100.00                      2.6
  54       Equiseti    100.00                      3.6
  55       Equiseti    100.00                      1.8

^1^ Growth inhibition was determined for 10 µg/mL of tebuconazole.
